Concepedia

Alissa Poteete

AP

16

Publications

2.4K

Citations

15

H-Index

2017

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

NYU Langone Health

The University of Texas Southwestern Medical Center

Massachusetts General Hospital

AstraZeneca (United Kingdom)

Alissa Poteete is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2017–2025

16

Publications

16

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Jacqulyne Robichaux, Yasir Y. Elamin, Zhi Tan et al. · Nature Medicine · 2018 · 443 citations · Full text

, , +12

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Jacqulyne Robichaux, Xiuning Le, R.S.K. Vijayan et al. · Nature · 2021 · 416 citations · Full text

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in <i>KRAS</i> -Mutant Lung Adenocarcinoma

Ana Galan Cobo, Piyada Sitthideatphaiboon, Xiao Qu et al. · Cancer Research · 2019 · 265 citations · Full text

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Jacqulyne Robichaux, Yasir Y. Elamin, R.S.K. Vijayan et al. · Cancer Cell · 2019 · 226 citations · Full text

, , +9

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

Monique B. Nilsson, Huiying Sun, Jacqulyne Robichaux et al. · Science Translational Medicine · 2020 · 171 citations · Full text

Rows per page

1–5 of 16